Authors
Latest:
AI: It’s not dermatologist vs. machineIn this month's Innovation article, Steve Xu, M.D., FAAD, highlights a company and innovator who are using artificial intelligence to augment physician decision-making, not replace it.
Latest:
Ultrasound technology may be useful treatment for rosaceaDrs. López and Kaufman discuss two new studies that examine the use of ultrasound technology as a new modality for treatment of erythematotelangiectatic and refractory rosacea.
Latest:
Clinical Pearls for Superficial and Medium Depth Chemical PeelsHarold J. Brody, MD, provides his best tips and tricks for superficial and medium depth chemical peels in a presentation at the 2022 ASDS Annual Meeting.
Latest:
DTC compounded medications: A treatment option for a system in need?How should dermatologists feel about direct-to-consumer online companies compounding prescription formulations? Read from three experts on the topic in this article.
Latest:
DTC compounded medications: A treatment option for a system in need?How should dermatologists feel about direct-to-consumer online companies compounding prescription formulations? Read from three experts on the topic in this article.
Latest:
DTC compounded medications: A treatment option for a system in need?How should dermatologists feel about direct-to-consumer online companies compounding prescription formulations? Read from three experts on the topic in this article.
Latest:
Spotlight on Dermira and the QBREXZA storyHans Hofland, Ph.D, and Dr. Steve Xu shine a spotlight on Dermira and its novel topical medicine indicated for primary axillary hyperhidrosis in patients 9 years of age and older.
Latest:
A successful ownership transitionTodd Petersen, CEO of VitalSkin Dermatology, discusses the last part of your transition journey – ensuring a smooth, successful transition for you, your team and your patients.
Latest:
Mind-body therapies effective for skin disordersCarol Soutor, M.D., writes about efficacy and safety of mind-body therapies for the treatment of various skin conditions.
Latest:
Advances in Itch: Brian S. Kim, MD, Shares Insights and Treatment TipsKim, who received the Marion B. Sulzberger Award at the 2024 American Academy of Dermatology Annual Meeting, discussed itch research an implications for clinical practice.
Latest:
Nuogen Pharma: Innovation in the fight against itchNuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.
Latest:
Practicing dermatology in the time of COVID-19Read one New York physician's insights on practice survival and patient care during the pandemic.
Latest:
CVS Removes Biosimilars From Drug ListOne notable change: CVS Caremark has removed the Humira biosimilar Amjevita and now prefers Hyrimoz and an unbranded biosimilar.
Latest:
Expanding NP and PA Opportunities in Dermatology PracticeAt the inaugural Horizons in Advanced Practice meeting, Douglas DiRuggiero, DMSc, MHS, PA-C, discussed how NPs and PAs can advance their professional growth by seizing opportunities to share their clinical experiences.
Latest:
The Role of Laser Treatments in Preventing Skin CancerPatricia Richey, MD, delves into efficacy of the 1927 and 1550 nanometer lasers to prevent skin cancers.
Latest:
Think Globally to Combat AcneTake a world tour of the global game-changing advances and home-grown success strategies dermatologists in the United States and abroad are using to tackle the challenges of acne.
Latest:
Navigating Vitiligo Treatment: Decoding Pigmentation & Accessing CareRocco Serrao, MD, FAAD, addresses potential barriers to access and affordability of narrowband UVB phototherapy and topical medications for vitiligo treatment, while highlighting available resources to assist patients in overcoming these obstacles.
Latest:
Atopic Dermatitis Remains Controlled Even After Reduction of Dupilumab DosePatients with persistently controlled atopic dermatitis who had their doses reduced were able to maintain their low disease activity.
Latest:
Designing the Ideal Topical: Relieving Itch and Improving Quality of LifePanelists discuss how an ideal topical for widespread psoriasis—including scalp and sensitive areas—would be a single, nonsteroidal, well-tolerated agent with steroidlike efficacy, capable of supporting both proactive flare prevention and rapid itch relief while improving adherence, quality of life, and long-term disease control.
Latest:
The Future of Exoceuticals and Innovative Aesthetics, According to Robin Smith, MD, MBARobin Smith, MD, MBA, discusses the future of regenerative aesthetics and her exosome-based skin care and hair care brand, Exoceuticals.
Latest:
South Beach Symposium 2025: A Comprehensive Dermatology EventMedical and aesthetic dermatologists partner at SBS 2025 to bridge gaps between clinical care and cosmetic procedures.
Latest:
Saving the World Through Pharmaceutical InnovationThe COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes.
Latest:
Doris Day, MD, Discusses Primary Axillary Hyperhidrosis and Brella SweatControl PatchBrella received FDA clearance last week for improving excessive underarm sweating.
Latest:
Expert Insights Highlight Novel ITK Inhibition With Soquelitinib for ADAlbert Chiou, MD, MBA, discusses early clinical data on soquelitinib for atopic dermatitis, highlighting its targeted ITK inhibition, dose-dependent efficacy, favorable safety profile, and more.
Latest:
Navigating Skin Aging Across Diverse Tones: Tailored Approaches and Cultural AwarenessAn expert in dermatology discusses the intricacies of addressing anti-aging concerns in patients with diverse skin tones, emphasizing the importance of tailoring management to meet their unique needs, understanding the underlying mechanisms of aging, and appreciating the cultural nuances within patient populations.
Latest:
Offering an Insurance Package to Retain and Reward Employees: What Dermatologists Should KnowExplore various elements that can go into a comprehensive insurance benefits package for dermatology practice employees.
Latest:
CBP/β-catenin Antagonists: A Safe and Novel Approach for Skin Rejuvenation and AgingTake a look at this overview of the top 5 considerations to show how CBP/β-catenin antagonists can be utilized for skin rejuvenation and anti-aging by enhancing Wnt/p300/β-catenin transcription.
